| Title : Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial - Henderson_2016_Lancet.Neurol_15_249 |
| Author(s) : Henderson EJ , Lord SR , Brodie MA , Gaunt DM , Lawrence AD , Close JC , Whone AL , Ben-Shlomo Y |
| Ref : Lancet Neurol , 15 :249 , 2016 |
| Abstract : Henderson_2016_Lancet.Neurol_15_249 |
| ESTHER : Henderson_2016_Lancet.Neurol_15_249 |
| PubMedSearch : Henderson_2016_Lancet.Neurol_15_249 |
| PubMedID: 26795874 |
| Title : The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen - Henderson_2013_BMC.Neurol_13_188 |
| Author(s) : Henderson EJ , Lord SR , Close JC , Lawrence AD , Whone A , Ben-Shlomo Y |
| Ref : BMC Neurol , 13 :188 , 2013 |
| Abstract : Henderson_2013_BMC.Neurol_13_188 |
| ESTHER : Henderson_2013_BMC.Neurol_13_188 |
| PubMedSearch : Henderson_2013_BMC.Neurol_13_188 |
| PubMedID: 24299497 |
| Title : The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems - Lawrence_1998_Neurochem.Res_23_787 |
| Author(s) : Lawrence AD , Sahakian BJ |
| Ref : Neurochem Res , 23 :787 , 1998 |
| Abstract : Lawrence_1998_Neurochem.Res_23_787 |
| ESTHER : Lawrence_1998_Neurochem.Res_23_787 |
| PubMedSearch : Lawrence_1998_Neurochem.Res_23_787 |
| PubMedID: 9566619 |
| Title : Alzheimer disease, attention, and the cholinergic system - Lawrence_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_43 |
| Author(s) : Lawrence AD , Sahakian BJ |
| Ref : Alzheimer Disease & Associated Disorders , 9 Suppl 2 :43 , 1995 |
| Abstract : Lawrence_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_43 |
| ESTHER : Lawrence_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_43 |
| PubMedSearch : Lawrence_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_43 |
| PubMedID: 8534423 |